Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. (XTNT) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · XTNT · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
1
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Xtant Medical Holdings, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
XTNT insider buying and selling by quarter
XTNT insider selling · XTNT insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · XTNT ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
XTNT executive sell shares · XTNT board member insider trading · XTNT insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Feb 15, 2026 | Schallenberger Mark A. COO | Other | 7,709 | $4K | Form 4 |
| Jan 15, 2026 | Neils Scott C CFO and Assistant Secretary | Other | 8,084 | $5K | Form 4 |
| Nov 15, 2025 | Vizirgianakis Stavros G. Director | Award | 553,797 | — | Form 4 |
| Nov 15, 2025 | Beeson Jonn R. Director | Award | 158,228 | — | Form 4 |
| Nov 15, 2025 | BAKEWELL JOHN K Director | Award | 158,228 | — | Form 4 |
| Nov 15, 2025 | JAIN ABHINAV Director | Award | 158,228 | — | Form 4 |
| Nov 15, 2025 | Lipschultz Tyler Director | Award | 158,228 | — | Form 4 |
| Nov 15, 2025 | Browne Sean E President and CEO · Director | Award | 394,937 | — | Form 4 |
| Nov 15, 2025 | Schallenberger Mark A. COO | Award | 292,253 | — | Form 4 |
| Nov 15, 2025 | Neils Scott C CFO and Assistant Secretary | Award | 263,291 | — | Form 4 |
| Aug 15, 2025 | Browne Sean E President and CEO · Director | Other | 10,605 | $7K | Form 4 |
| Aug 15, 2025 | Neils Scott C CFO | Other | 34,131 | $22K | Form 4 |
| Apr 10, 2025 | ORBIMED ADVISORS LLC 10 percent owner | Sale | 17,109,618 | $7.19M⚡ | Form 4 |
| Jan 15, 2025 | Neils Scott C CFO | Other | 7,986 | $4K | Form 4 |
| Oct 15, 2024 | Browne Sean E President and CEO · Director | Other | 105,442 | $62K | Form 4 |
| Aug 15, 2024 | Vizirgianakis Stavros G. Director | Award | 505,405 | — | Form 4 |
| Aug 15, 2024 | Vizirgianakis Stavros G. Director | Award | 243,243 | — | Form 4 |
| Aug 15, 2024 | MITCHELL-KELLER LORI D Director | Award | 162,162 | — | Form 4 |
| Aug 15, 2024 | McNamara Robert Director | Award | 162,162 | — | Form 4 |
| Aug 15, 2024 | Beeson Jonn R. Director | Award | 162,162 | — | Form 4 |
| Aug 15, 2024 | BAKEWELL JOHN K Director | Award | 162,162 | — | Form 4 |
| Aug 15, 2024 | Brandt Kevin D Chief Commercial Officer | Other | 56,333 | $34K | Form 4 |
| Aug 15, 2024 | Neils Scott C CFO | Other | 34,132 | $20K | Form 4 |
| Aug 15, 2024 | Browne Sean E President and CEO · Director | Other | 10,606 | $6K | Form 4 |
| Apr 3, 2024 | Brandt Kevin D Chief Commercial Officer | Award | 184,209 | — | Form 4 |
Neils Scott C
CFO and Assistant Secretary
Date
Jan 15
Shares
8,084
Price
$0.65
Value
$5K
Browne Sean E
President and CEO · Director
Date
Nov 15
Shares
394,937
Price
—
Value
—
Neils Scott C
CFO and Assistant Secretary
Date
Nov 15
Shares
263,291
Price
—
Value
—
Browne Sean E
President and CEO · Director
Date
Aug 15
Shares
10,605
Price
$0.63
Value
$7K
ORBIMED ADVISORS LLC
10 percent owner
Date
Apr 10
Shares
17,109,618
Price
$0.42
Value
$7.19M ⚡
Browne Sean E
President and CEO · Director
Date
Oct 15
Shares
105,442
Price
$0.59
Value
$62K
Brandt Kevin D
Chief Commercial Officer
Date
Aug 15
Shares
56,333
Price
$0.60
Value
$34K
Browne Sean E
President and CEO · Director
Date
Aug 15
Shares
10,606
Price
$0.60
Value
$6K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About XTNT insider trading
XTNT insider trades
Xtant Medical Holdings, Inc. (XTNT) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Neils Scott C (CFO and Assistant Secretary), Schallenberger Mark A. (COO), Browne Sean E (President and CEO · Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. XTNT insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Xtant Medical Holdings, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
XTNT insider trading · 5 questionsThe insiders of Xtant Medical Holdings, Inc. (XTNT) include executives and directors such as Neils Scott C (CFO and Assistant Secretary), Schallenberger Mark A. (COO), Browne Sean E (President and CEO · Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026